Anti-CD20 for rheumatoid arthritis

被引：0
|
作者：
Edwards, JC [1 ]
Leandro, MJ [1 ]
Cambridge, G [1 ]
机构：
[1] UCL, London, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2004年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [41] Successful Treatment of Digital Tip Necrosis in Rheumatoid Vasculitis With Anti-CD20 Antibody Rituximab
    Korkosz, Mariusz
    Krolczyk, Jaroslaw
    Telesinska-Jasiowka, Dorota
    Grodzicki, Tomasz
    [J]. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2013, 19 (01) : 43 - 45
  • [42] Rituximab (anti-CD20) zur Behandlung von bullösen AutoimmundermatosenRituximab (anti-CD20) for the treatment of autoimmune bullous diseases
    M. Kasperkiewicz
    D. Zillikens
    [J]. Der Hautarzt, 2007, 58 (2): : 115 - 121
  • [43] Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis
    Maria Rehnberg
    Sylvie Amu
    Andrej Tarkowski
    Maria I Bokarewa
    Mikael Brisslert
    [J]. Arthritis Research & Therapy, 11
  • [44] THE ANTI-CD20 ANTIBODY RITUXIMAB REDUCES THE INFLAMMATORY AND PROTHROMBOTIC PROFILE OF LEUKOCYTES FROM RHEUMATOID ARTHRITIS PATIENTS AND MODULATES THE ACTIVITY OF ENDOTHELIAL CELLS
    Cecchi, I.
    Perez-Sanchez, C.
    Ruiz-Limon, P.
    de la Rosa, I. Arias
    Abalos-Aguilera, M. C.
    Jimenez-Gomez, Y.
    Ortega, R.
    Collantes-Estevez, E.
    Escudero, A.
    Barbarroja, N.
    Sciascia, S.
    Lopez-Pedrera, C.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 497 - 497
  • [45] Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity
    Kormelink, T. Groot
    Tekstra, J.
    Thurlings, R. M.
    Boumans, M. H. J.
    Vos, K.
    Tak, P. P.
    Bijlsma, J. W. J.
    Lafeber, F. P. J. G.
    Redegeld, F. A.
    van Roon, J. A. G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (12) : 2137 - 2144
  • [46] Short- and long-term effects of anti-CD20 treatment on B cell ontogeny in bone marrow of patients with rheumatoid arthritis
    Rehnberg, Maria
    Amu, Sylvie
    Tarkowski, Andrej
    Bokarewa, Maria I.
    Brisslert, Mikael
    [J]. ARTHRITIS RESEARCH & THERAPY, 2009, 11 (04)
  • [47] Ofatumumab, a human anti-CD20 monoclonal antibody
    Osterborg, Anders
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2010, 10 (03) : 439 - 449
  • [48] Anti-CD20 monoclonal antibody in autoimmune diseases
    Pogliani, EM
    Larocca, A
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2002, 56 (07) : 350 - 351
  • [49] Dental Adverse Effects of Anti-CD20 Therapies
    Bartak, Helene
    Fareh, Tasnim
    Ben Othman, Nouha
    Viard, Delphine
    Cohen, Mikael
    Rocher, Fanny
    Ewig, Elliot
    Drici, Milou-Daniel
    Lebrun-Frenay, Christine
    [J]. NEUROLOGY AND THERAPY, 2024, 13 (03) : 917 - 930
  • [50] Anti-CD20 monoclonal antibodies in multiple sclerosis
    Moreno Torres, Irene
    Garcia-Merino, Antonio
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2017, 17 (04) : 359 - 371
12345